The choice between a ritonavir-boosted protease inhibitor- and a non-nucleoside reverse transcriptase inhibitor-based regimen for initiation of antiretroviral treatment – results from an observational study in Germany

BACKGROUND: This study aims at identifying predictors of the treatment decision of German physicians with regard to a non-nucleoside reverse transcriptase inhibitor (NNRTI) or a ritonavir-boosted protease inhibitor (PI/r) -based initial treatment regimen. METHODS: The study is based on a sub analysi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Pharm Policy Pract
Main Authors: Mahlich, Jörg, Groß, Mona, Kuhlmann, Alexander, Bogner, Johannes, Heiken, Hans, Stoll, Matthias
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5203724/
https://ncbi.nlm.nih.gov/pubmed/28050254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40545-016-0092-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados